Latest Pharmaceutical Insights
Andrei Kuzmik Shutterstock
Optimising the future patient centricity of prefilled syringes
Marcelo Cruz, VP of business Development and Marketing at Tjoapack, explores the secondary innovations poised to revolutionise the patient centricity of PFSs over the next decade.
21 Mar 2025
Likarda
The new approach to HRT delivery
Charles Virden, founder and CEO of VitalTE, and Lisa Stehno-Bittel, president and founder of Likarda, discuss a new approach to HRT delivery that would allow self-administration through infrequent injection.
20 Mar 2025
eXmoor
Considerations for process design to improve cell therapy manufacturing
Harvey Branton, senior translational consultant at cell and gene therapy CDMO eXmoor Pharma, shares insights into early process development, exploring common misconceptions that could impact long-term manufacturing success for ATMP developers.
19 Mar 2025
Pharmaceutical Insights + Pharmaceutical Manufacturing Insights
PCI Pharma Services
Avoiding PPQ Pitfalls
Aimee Hodge, VP business operations development & manufacturing at PCI Pharma Services discusses PPQ pitfalls and how to avoid them.
18 Mar 2025
Pharmaceutical Insights + Pharmaceutical Manufacturing Insights
vetre Shutterstock
Are we moving fast enough?
It’s been a few months since I stepped into the role of editor at EPM, and in that time, one topic has consistently stood out in conversations, industry events, and press releases—sustainability.
17 Mar 2025
LEWA
Efficient Material Separation: Use of bellows pulsators in extraction processes
In the chemical and pharmaceutical industries, mixtures of substances must often be separated. However, if the substances to be separated have similar boiling points or the energy required must be minimised.
13 Mar 2025
Powering digital transformation in drug discovery
Shafique Virani, chief corporate development officer and interim chief medical officer, Recursion, delves into digital transformation within drug discovery and the power of AI-enabled platforms in the future of therapeutics.
7 Dec 2022
The regulatory shift: Laboratory services post-Brexit
Chris Allen, CEO of UK-based analytical testing and scientific consultancy provider Broughton, explains the challenges — and opportunities — that Brexit holds for laboratory services.
12 Oct 2022
Perspective on pharma: Post-pandemic lessons
Noel Maestre, PE, vice president of Life Sciences, and David Estape, technology manager Biotechnology at CRB discuss how virus response rewrote the playbook for vaccine response, but even more change is necessary to deal with emerging threats.
12 May 2022
How pharmaceutical manufacturers can benefit from moving to cloud today
For pharmaceuticals manufacturers, progressing digitalisation and moving to the cloud has been notoriously slow, and misperceptions of what moving to the cloud entails have been a significant factor in this lack of adoption.
12 May 2022
Driving drug discovery with micromotors
Dave Walsha, sales manager at precision drive system supplier, Electrical Mechanical Systems (EMS), explores how micromotors are helping drug discovery.
25 Apr 2022
Pharmaceutical Insights + Pharmaceutical Manufacturing Insights
Cancer immunotherapy: the best is yet to come
Justin Wilson, partner and attorney at Withers & Rodgers, discusses his opinion on the promising innovations in the microbiome and the role of IP in supporting the discovery of new drugs and treatments.
13 Apr 2022
Sorry, no results.
Sponsored Content
Stevanato Group
A one-stop shop for even the most challenging Monoclonal Antibodies (mAbs)
The biologics market is expanding rapidly – with a compound annual growth rate of 15% predicted until 2027. But this new generation of drugs comes with unique challenges that require an innovative approach underpinned by extensive experience.
12 Mar 2025
08:00
White Papers
Mini Tabs Dosage Accuracy: Are you Gambling With Patient Safety?
Mini-tabs offer unprecedented flexibility in drug delivery, but not without significant challenges. Download this guide to learn how to achieve certainty with weight control and analysis challenges in R&D and Production.
Sorry, no results.
Sponsored Content
Stevanato Group
A one-stop shop for even the most challenging Monoclonal Antibodies (mAbs)
The biologics market is expanding rapidly – with a compound annual growth rate of 15% predicted until 2027. But this new generation of drugs comes with unique challenges that require an innovative approach underpinned by extensive experience.
12 Mar 2025
08:00